Last reviewed · How we verify

NCT05668715

Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive Bladder

Status unknown NA Last updated 30 December 2022
What this trial tests

NA trial testing Transcutaneous tibial nerve stimulation (TTNS) in Urinary Bladder, Overactive in 40 participants. Status unknown.

Timeline
1 January 2023
Primary endpoint
1 June 2023
30 June 2023

Quick facts

Lead sponsorPamukkale University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date1 January 2023
Primary completion1 June 2023
Estimated completion30 June 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Pamukkale University

Who can join

18 and older, female only, with Urinary Bladder, Overactive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study is the first prospective trial that compares the efficacy of TTNS in antimuscarinic naive and refractory women with idiopathic OAB. In this study, it was aimed to compare the effectiveness of TTNS on quality of life (QoL) and clinical parameters related to OAB in antimuscarinic naive and refractory women. The results of this study would make it easier to understand the place of TTNS among the treatment options in women with idiopathic OAB.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcutaneous tibial nerve stimulation (TTNS)

Trials testing the same drug.

Other recruiting trials for Urinary Bladder, Overactive

Currently open trials in the same condition.

Other Pamukkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05668715.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing